Related references
Note: Only part of the references are listed.Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study
Arno Floore et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme
N. J. Polman et al.
PREVENTIVE MEDICINE (2019)
HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
Emma Altobelli et al.
CANCER MEDICINE (2019)
Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study
Wieke W. Kremer et al.
BMJ OPEN (2019)
Long-term CIN3+risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis
Stefanie Dick et al.
GYNECOLOGIC ONCOLOGY (2019)
Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis
Helen Kelly et al.
BRITISH JOURNAL OF CANCER (2019)
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up
Lise M. A. De Strooper et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
Wina Verlaat et al.
EPIGENETICS (2018)
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Marc Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)
Roosmarijn Luttmer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
Roosmarijn Luttmer et al.
BRITISH JOURNAL OF CANCER (2016)
Management of high-risk HPV-positive women for detection of cervical (pre)cancer
Roosmarijn Luttmer et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
Lyndsay Ann Richardson et al.
CANCER CYTOPATHOLOGY (2015)
HPV testing with cytology triage for cervical cancer screening in routine practice
Karolina Louvanto et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Combined CADM1/MAL Methylation and Cytology Testing for Colposcopy Triage of High-Risk HPV-Positive Women
Lise M. A. De Strooper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2/3 Lesions
Lise M. A. De Strooper et al.
CANCER PREVENTION RESEARCH (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial
Viola M. J. Verhoef et al.
LANCET ONCOLOGY (2014)
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Renske D. M. Steenbergen et al.
NATURE REVIEWS CANCER (2014)
Benchmarking CIN 3+Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
D. C. Rijkaart et al.
BRITISH JOURNAL OF CANCER (2012)
Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening
Dorien C. Rijkaart et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
Pontus Naucler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
Guglielmo Ronco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Achievements and limitations of cervical cytology screening
Henry C. Kitchener et al.
VACCINE (2006)
Share Paper
